Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

EVFM

Evofem Biosciences, Inc.

Healthcare · USD

Set alert

Price alert · EVFM

All alert types
0.01 USD 0.00 0.00%
As of Oct 30, 2026
0.006 Day range 0.0063
0.006 52-week range 0.013
YTD
-40.00%
1 year
-50.00%
Open
0.0063
Prev close
0.006
Mkt cap
795.18K
Vol
14.92K
Avg vol
170.68K
EPS
-0.12
P/E
0.00
Div yield
0.00%
More statistics
Low
0.006
High
0.0063
Forward P/E
-0.48
Beta
-1.68
Short ratio
0.19
Inst. own
9.67%
Dividend
0.00
Ex-div date
50-d avg
0.74126
200-d avg
3.61
1y target
11.05

5D chart

Chart tools
Interval
1m5m15m30m
EVFM five-day price chart0.010.010.010.010.01Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-182.94 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 4.3×
FY 2016: -1.2×FY 2017: -0.3×FY 2018: -0.7×FY 2019: -3.1×FY 2020: -1.1×FY 2021: -0.2×FY 2022: -0.0×FY 2023: 0.0×FY 2024: -0.1×FY 2025: 4.3×
FY 2016 5y median -0.0× FY 2025
P/S 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 363×FY 2021: 6.0×FY 2022: 0.2×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
P/B -0.0×
FY 2016: 1.3×FY 2017: -0.3×FY 2018: -3.9×FY 2019: 15.9×FY 2020: 120×FY 2021: -0.5×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
P/FCF -0.6×
FY 2016: -1.0×FY 2017: -1.4×FY 2018: -1.6×FY 2019: -4.4×FY 2020: -1.5×FY 2021: -0.3×FY 2022: -0.1×FY 2023: -0.0×FY 2024: -0.2×FY 2025: -0.6×
FY 2016 5y median -0.2× FY 2025
EV/EBITDA 26.7×
FY 2016: -0.3×FY 2017: -0.2×FY 2018: -0.8×FY 2019: -2.9×FY 2020: -1.2×FY 2021: -0.9×FY 2022: -0.9×FY 2023: -2.7×FY 2024: -6.7×FY 2025: 26.7×
FY 2016 5y median -0.9× FY 2025
EV/Sales 2.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 395×FY 2021: 19.1×FY 2022: 4.3×FY 2023: 2.4×FY 2024: 2.4×FY 2025: 2.7×
FY 2016 5y median 2.7× FY 2025
FCF Yield -170.0%
FY 2016: -105.1%FY 2017: -71.3%FY 2018: -61.6%FY 2019: -22.8%FY 2020: -66.8%FY 2021: -303.9%FY 2022: -1897.9%FY 2023: -2904.4%FY 2024: -408.3%FY 2025: -170.0%
FY 2016 5y median -408.3% FY 2025

Profitability

Gross Margin 74.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -269.7%FY 2021: 50.8%FY 2022: 73.8%FY 2023: 64.3%FY 2024: 80.2%FY 2025: 74.7%
FY 2016 5y median 73.8% FY 2025
Operating Margin 7.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -23234.1%FY 2021: -2023.3%FY 2022: -499.6%FY 2023: -98.0%FY 2024: -39.6%FY 2025: 7.1%
FY 2016 5y median -98.0% FY 2025
Net Margin 1.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -31907.8%FY 2021: -2489.0%FY 2022: -455.5%FY 2023: 290.8%FY 2024: -45.8%FY 2025: 1.9%
FY 2016 5y median -45.8% FY 2025
ROE -0.6%
FY 2016: -109.3%FY 2017: 105.6%FY 2018: 538.2%FY 2019: -511.9%FY 2020: -10564.9%FY 2021: 206.1%FY 2022: 106.8%FY 2023: -79.7%FY 2024: 12.4%FY 2025: -0.6%
FY 2016 5y median 12.4% FY 2025
ROIC -14.2%
FY 2016: -101.1%FY 2017: 35.9%FY 2018: 402.1%FY 2019: -333.1%FY 2020: -118.6%FY 2021: -1035.6%FY 2022: 12518.5%FY 2023: 96.2%FY 2024: 71.7%FY 2025: -14.2%
FY 2016 5y median 71.7% FY 2025
ROA 1.9%
FY 2016: -101.6%FY 2017: -2664.6%FY 2018: -3135.0%FY 2019: -282.9%FY 2020: -129.4%FY 2021: -482.7%FY 2022: -304.8%FY 2023: 502.0%FY 2024: -37.2%FY 2025: 1.9%
FY 2016 5y median -37.2% FY 2025

Growth (YoY)

Revenue 4.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 1748.4%FY 2022: 104.2%FY 2023: 8.2%FY 2024: 6.3%FY 2025: 4.2%
FY 2016 FY 2025
Operating Income 118.7%
FY 2016: 71.4%FY 2017: -196.3%FY 2018: -117.6%FY 2019: 32.1%FY 2020: -96.5%FY 2021: -61.0%FY 2022: 49.6%FY 2023: 78.8%FY 2024: 57.0%FY 2025: 118.7%
FY 2016 FY 2025
EPS (diluted) 100.0%
FY 2016: 70.1%FY 2017: -706.7%FY 2018: 87.4%FY 2019: 65.3%FY 2020: -6.5%FY 2021: 25.4%FY 2022: 94.4%FY 2023: 100.0%FY 2024: -280.9%FY 2025: 100.0%
FY 2016 FY 2025
Free Cash Flow 48.8%
FY 2016: 57.4%FY 2017: -18.4%FY 2018: -193.6%FY 2019: -0.1%FY 2020: -91.2%FY 2021: -38.3%FY 2022: 52.7%FY 2023: 87.3%FY 2024: 56.5%FY 2025: 48.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.2×
FY 2016: 13.9×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 2.1×FY 2020: 1.3×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.2×
FY 2016: 13.9×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 2.1×FY 2020: 1.2×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
Debt / Equity -0.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -0.2×FY 2019: 0.0×FY 2020: 63.8×FY 2021: -1.2×FY 2022: -1.0×FY 2023: -0.7×FY 2024: -0.6×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
Net Debt / EBITDA 26.1×
FY 2016: 1.0×FY 2017: 0.0×FY 2018: -0.0×FY 2019: 0.2×FY 2020: -0.1×FY 2021: -0.7×FY 2022: -0.8×FY 2023: -2.7×FY 2024: -6.5×FY 2025: 26.1×
FY 2016 5y median -0.8× FY 2025
Interest Coverage 0.5×
FY 2016: -11.6×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.5×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 10.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 10.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 29.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -0.1%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 29.9%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31